The enhanced in vitro hematopoietic activity of leridistim, a chimeric dual G-CSF and IL-3 receptor agonist (Q77769425)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

The enhanced in vitro hematopoietic activity of leridistim, a chimeric dual G-CSF and IL-3 receptor agonist (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

0 references

Abegg AL

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Vickery LE

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Bremer ME

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Donnelly AM

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Doshi PD

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Evans ML

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Thurman TL

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Braford SR

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Caparon MH

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Bauer SC

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Giri JG

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Welply JK

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

McKearn JP

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Smith WG

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

English

0 references

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

316-326

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896534%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402366

8 December 2019

exact match

0 references

cites work

Clinical use of hematopoietic growth factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Clinical use of hematopoietic growth factors in the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Ran

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Growth Regulation of Hematopoietic Cells :An overview

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Interleukin-3: structure and function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Stimulation of human hematopoietic colony formation by recombinant gibbon multi-colony-stimulating factor or interleukin 3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

The panspecific hemopoietin of activated T lymphocytes (interleukin-3).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Saturation mutagenesis of human interleukin-3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Use of combinatorial mutagenesis to select for multiply substituted human interleukin-3 variants with improved pharmacologic properties

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Administration of daniplestim and granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Mobilization of peripheral-blood stem cells by concurrent administration of daniplestim and granulocyte colony-stimulating factor in patients with breast cancer or lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Circular permutation of the granulocyte colony-stimulating factor receptor agonist domain of myelopoietin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Bivalent binding and signaling characteristics of Leridistim, a novel chimeric dual agonist of interleukin-3 and granulocyte colony-stimulating factor receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Suppression of apoptosis: role in cell growth and neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Enhanced ability of daniplestim and myelopoietin-1 to suppress apoptosis in human hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Circular permutation of granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Collagen matrix: an attractive alternative to agar and methylcellulose for the culture of hematopoietic progenitors in autologous transplantation products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Terminal differentiation of hemopoietic cell clones cultured in tridimensional collagen matrix: in situ cell morphology and enzyme histochemistry analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Endogenous erythroid and megakaryocytic colony formation in serum-free, cytokine-free collagen gels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Differential expression of receptors for hemopoietic growth factors on subsets of CD34+ hemopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021

Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402366

7 January 2021